In Engineered slow-acting insulin (Lantus) the asparagine residue 21 o – McqOptions

MCQOPTIONS

1.	In Engineered slow-acting insulin (Lantus) the asparagine residue 21 of the A chain is replaced by glycine, and this chain is elongated at its C-terminal end by two arginine residues.
A.	True
B.	False
Answer» C.

Discussion

No Comment Found

Related MCQs

Which of the following ion co-ordinates the oligomerization of three insulin dimers to form a hexamer?
Which of the following amino acid when inserted in the insulin chain significantly reduces the monomeric interactions?
In Engineered slow-acting insulin (Lantus) the asparagine residue 21 of the A chain is replaced by glycine, and this chain is elongated at its C-terminal end by two arginine residues.
The introduction of amino acid substitutions that will discourage the monomer interaction is to be done inside the insulin receptor binding site.
Which of the following is the trade name of engineered slow-acting insulin?
Find the odd one out with respect to engineered fast-acting insulins.
Engineered slow-acting insulin is not fully soluble at which of the following pH?
Which of the following amino acid cannot be inserted to minimize the monomer interactions?
Which of the following cells are destroyed in type 1 diabetes?
A combination of fast-acting and slow-acting insulin must usually be administered to diabetics to mimic the natural state.